Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
ACS Nano · 2024
DOI: 10.1021/acsnano.4c00392 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2024. Verfasst von Zixu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang 110116, China. Hauptthemen laut MEDLINE: Cancer Vaccines, Immunotherapy, Polyesters, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Liaoning Livelihood Science and Technology Plan Joint Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics Science, Shenyang Pharmaceutical University, Shenyang 110116, China.
- Department of Pharmaceutics, College of Pharmacy Sciences, Jilin University, Changchun 130021, China.
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China.
ORCID-Profile: Haibing He, Yu Zhang, Xing Tang
Förderung
- National Key Research and Development Program of China
- Liaoning Livelihood Science and Technology Plan Joint Project
Zitieren
APA
Liu, Z., Liu, B., Feng, Y., Zhao, L., Wang, Q., He, H., Yin, T., Zhang, Y., Yang, L., Gou, J., & Tang, X. (2024). Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.4c00392
Vancouver
Liu Z, Liu B, Feng Y, Zhao L, Wang Q, He H, et al. Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy. ACS Nano. 2024. doi:10.1021/acsnano.4c00392
BibTeX
@article{Liu2024,
author = {Liu, Zixu and Liu, Boyuan and Feng, Yupeng and Zhao, Linxuan and Wang, Qingqing and He, Haibing and Yin, Tian and Zhang, Yu and Yang, Li and Gou, Jingxin and Tang, Xing},
title = {Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy},
journal = {ACS Nano},
year = {2024},
doi = {10.1021/acsnano.4c00392}
}
EUVIMED